Biotech RadarJobs updated

COMPANY

Sorriso Pharmaceuticals

HQ: Sandy, UT source · sorrisopharma.com ↗

Clinical Phase 1

Keywords: immunology inhaled Crohn's disease ulcerative colitis inflammatory bowel disease SOR102

Location: Sandy, UT · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT06080048A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative ColitisPhase 1CompletedOct 24, 2023Oct 16, 2024 (actual)
Feedback